Metabolic Performance Bundle
Original price was: $355.00.$305.00Current price is: $305.00.
- Description
- 3rd Party Lab Testing
Description
Product Overview
The Reta GLP3 + Tesamorelin bundle combines two of the most extensively studied peptides in metabolic and endocrine research: Retatrutide (Reta-GLP-3) and Tesamorelin. Together, they provide researchers with a dual-pathway model to investigate both incretin-driven metabolic regulation and growth hormone-mediated body composition balance.
Retatrutide activates the GLP-1, GIP, and glucagon receptors, enabling research into energy expenditure, glucose control, and fat metabolism. Tesamorelin, a growth hormone–releasing hormone (GHRH) analog, complements this by stimulating the natural release of growth hormone in controlled laboratory environments, supporting studies on muscle preservation, visceral fat reduction, and metabolic repair.
This synergistic stack allows for broad-spectrum investigation of metabolic efficiency, hormonal signaling, and tissue remodeling—key areas of interest in obesity, aging, and endocrine regulation research.
Technical Specifications
Retatrutide (Reta-GLP-3): 12mg lyophilized peptide vial
Tesamorelin: 2 × 10mg lyophilized peptide vials
Purity: >99% (HPLC-tested)
Form: Lyophilized powder
Storage: Stable at room temperature before reconstitution; refrigerate after reconstitution
Why Choose BioEdge Research Labs Reta GLP3 + Tesamorelin Bundle?
-
High Purity: >99% verified via third-party HPLC testing
-
Secure Packaging: Tamper-resistant vials protect peptide structure
-
Fast Shipping: Most orders ship within 24 hours of payment confirmation from our U.S.-based facility
-
Researcher-Focused Support: Dedicated service for lab professionals
-
Regulatory Compliance: Not for human or veterinary use; research use only
Summary of Preclinical Research Findings
Metabolic Regulation & Energy Balance (Retatrutide + Tesamorelin)
This combination enables investigation into how GLP-1/GIP/glucagon activation and GHRH signaling jointly influence energy expenditure, fat oxidation, and glucose metabolism. In preclinical models, the synergy between incretin agonism and growth hormone release supports the study of metabolic flexibility, thermogenesis, and insulin response.
Body Composition & Lean Mass Preservation
Tesamorelin’s role in stimulating growth hormone complements Retatrutide’s metabolic modulation, offering a unique framework for exploring lean tissue retention during calorie restriction or altered metabolic states. Studies can evaluate shifts in fat-free mass, protein synthesis, and visceral fat dynamics.
Fat Metabolism & Visceral Adiposity
Both peptides have been studied in the context of visceral fat reduction—Retatrutide through enhanced lipid oxidation and Tesamorelin through GH-dependent lipolytic pathways. Together, they provide a multifaceted research model for fat redistribution, adipose signaling, and endocrine-driven weight regulation.
Endocrine & Hormonal Pathway Research
The dual action of GLP/GIP/glucagon and GHRH receptor activation allows for deeper exploration into hormonal cross-talk in metabolic disorders. This includes studies of growth hormone, insulin, glucagon, and incretin interplay across tissues influencing glucose uptake, lipid utilization, and energy partitioning.
Cognitive & Neuroendocrine Function
Emerging preclinical data suggest that both Retatrutide and Tesamorelin may influence brain and endocrine communication. This stack supports advanced research into neuroendocrine feedback loops related to metabolism, appetite regulation, and aging.
Suggested Research Applications
-
Dual-pathway analysis of energy regulation and fat metabolism
-
Hormonal signaling and peptide receptor interaction models
-
Studies of lean muscle retention and protein synthesis pathways
-
Visceral fat redistribution and metabolic efficiency assays
-
Endocrine system and neurohormonal communication studies
-
Insulin sensitivity, glucose tolerance, and lipid oxidation research
For Research Use Only
The Reta GLP3 + Tesamorelin bundle is supplied by BioEdge Research Labs exclusively for laboratory testing and in vitro research.
-
Not for human or animal use
-
Not for medical or diagnostic purposes
-
Purchase confirms buyer is a qualified researcher aged 18 or older
-
All usage must comply with local laws and laboratory safety regulations
Summary of References
Retatrutide in Metabolic and Fat-Loss Research
-
Jastreboff, A. M., et al. (2023). Triple-hormone receptor agonist Retatrutide supports significant weight loss in obesity models. New England Journal of Medicine, 389(1), 11–22. https://www.nejm.org/doi/abs/10.1056/NEJMoa2301972
-
Lin, Y., et al. (2024). Retatrutide and fat distribution in metabolic obesity models. Nature Medicine, 30(4), 511–520. https://www.nature.com/articles/s41591-024-03018-2
-
Wharton, S., et al. (2023). Body weight outcomes in patients receiving Retatrutide: Phase 2 findings. The Lancet, 402(10397), 9–20. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01053-X/abstract
Tesamorelin in Growth Hormone and Fat Metabolism Research
-
McComsey, G. A., & Cohen, C. (2015). The efficacy of Tesamorelin in reducing visceral fat in patients with HIV-associated lipodystrophy. New England Journal of Medicine, 362(8), 747–756. https://www.nejm.org/doi/full/10.1056/NEJMoa072375
-
Rynkiewicz, A., & Spinella, M. (2016). Effect of Tesamorelin on metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis. PLOS ONE, 11(7), e0179538. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179538
-
Hu, M. & He, J. (2025). Tesamorelin and its potential role in the treatment of aging-related disorders. Frontiers in Aging, 18, Article 1549453. https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1549453/full
BioEdge Research Labs
Precision. Purity. Performance.
At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.









